Verax Biomedical Obtains $12,554,365 New Round

  • Feed Type
  • Date
    3/2/2016
  • Company Name
    Verax Biomedical
  • Mailing Address
    148 Bartlett Street Marlborough, MA 01752 USA
  • Company Description
    Verax Biomedical is a leader in the development of rapid tests designed to detect a broad range of bacterial contaminants based upon its proprietary Pan Genera Detection (PGD) technology.
  • Website
    http://www.veraxbiomedical.com
  • Transaction Type
    Venture Equity, Debt
  • Transaction Amount
    $12,554,365
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 56 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy